---  
layout: startup_page  
title: "Nuvig Therapeutics"  
id: "nuvigtherapeutics.com"  
permalink: "/nuvigtherapeuticsnuvigtherapeutics.com12052024/"  
website: "https://www.nuvigtherapeutics.com/"  
funding_round: "Series B"  
funding_amount: "$161M"  
investors: "Sanofi Ventures, Blue Owl Healthcare Opportunities, Norwest Venture Partners, B Capital, Leaps by Bayer, Global BioAccess Fund, LOTTE Holdings, Alexandria Venture Investments, abrdn Inc., Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital"  
about: "Nuvig Therapeutics is a clinical-stage biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases. Their lead candidate, NVG-2089, is a first-in-class immunomodulator designed to improve autoimmune dysregulation without immunosuppression. The company aims to deliver novel methods for reducing autoimmune dysregulation."  
markets: "Biotechnology, Pharmaceuticals, Immunomodulators, Autoimmune Diseases, Health Care, Therapeutics, Drug Discovery, HealthTech, Life Sciences"  
hq: "Redwood City, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/nuvig-therapeutics-inc"  
twitter: "https://twitter.com/nuvigtx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/nuvig-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/495401-41"  

date_display: "05-Dec-2024"  
date: "2024-12-05"

# SEO Optimization  
meta_title: "Nuvig Therapeutics - Series B Funding ($161M)"  
meta_description: "Nuvig Therapeutics, Nuvig Therapeutics is a clinical-stage biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune ..."  
meta_keywords: "Nuvig Therapeutics, Biotechnology, Pharmaceuticals, Immunomodulators, Autoimmune Diseases, Health Care, Therapeutics, Drug Discovery, HealthTech, Life Sciences, Series B funding"  
canonical_url: "https://startup.projectstartups.com/nuvigtherapeuticsnuvigtherapeutics.com12052024/"  
---